Beam Therapeutics Inc. Increase Decrease In Operating Lease Liability
Beam Therapeutics Inc. (BEAM) reported Increase Decrease In Operating Lease Liability of -$7.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-04
- Beam Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$3.53M.
- Beam Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$3.49M.
- Beam Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$3.50M.
- Beam Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$3.38M.
- Beam Therapeutics Inc. increase decrease in operating lease liability for fiscal 2025 was -$13.51M.
- Beam Therapeutics Inc. increase decrease in operating lease liability for fiscal 2024 was -$12.95M.
- Beam Therapeutics Inc. increase decrease in operating lease liability for fiscal 2023 was -$10.17M, a 181.80% decline from fiscal 2022.
- Beam Therapeutics Inc. increase decrease in operating lease liability for fiscal 2022 was $12.43M, a 22.45% decline from fiscal 2021.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$7.02M 10-Q · filed 2026-08-04 | -$10.52M derived: sum of 3 quarters · filed 2026-08-04 | -$13.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$3.49M 10-Q · filed 2026-05-07 | -$6.99M derived: sum of 2 quarters · filed 2026-05-07 | -$10.38M derived: sum of 3 quarters · filed 2026-05-07 | -$13.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$6.88M derived: sum of 2 quarters · filed 2026-02-24 | -$10.21M derived: sum of 3 quarters · filed 2026-08-04 | -$13.51M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$6.71M derived: sum of 2 quarters · filed 2026-08-04 | -$10.01M 10-Q · filed 2025-11-04 | -$13.28M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$6.62M 10-Q · filed 2026-08-04 | -$9.90M derived: sum of 3 quarters · filed 2026-08-04 | -$13.33M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$3.30M 10-Q · filed 2026-05-07 | -$6.57M derived: sum of 2 quarters · filed 2026-05-07 | -$10.01M derived: sum of 3 quarters · filed 2026-05-07 | -$13.14M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$6.71M derived: sum of 2 quarters · filed 2026-02-24 | -$9.84M derived: sum of 3 quarters · filed 2026-02-24 | -$12.95M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$6.57M derived: sum of 2 quarters · filed 2025-11-04 | -$9.68M 10-Q · filed 2025-11-04 | -$12.68M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$3.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$6.24M 10-Q · filed 2025-08-05 | -$9.25M derived: sum of 3 quarters · filed 2026-02-24 | -$12.36M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$3.11M 10-Q · filed 2025-05-06 | -$6.12M derived: sum of 2 quarters · filed 2026-02-24 | -$9.22M derived: sum of 3 quarters · filed 2026-02-24 | -$10.73M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$6.11M derived: sum of 2 quarters · filed 2026-02-24 | -$7.62M derived: sum of 3 quarters · filed 2026-02-24 | -$10.17M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$4.61M derived: sum of 2 quarters · filed 2024-11-05 | -$7.16M 10-Q · filed 2024-11-05 | -$8.23M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$4.05M 10-Q · filed 2024-08-06 | -$5.12M derived: sum of 3 quarters · filed 2025-02-25 | -$3.97M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$2.55M 10-Q · filed 2024-05-07 | -$3.62M derived: sum of 2 quarters · filed 2025-02-25 | -$2.46M derived: sum of 3 quarters · filed 2025-02-25 | $11.66M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $85.00K derived: sum of 2 quarters · filed 2025-02-25 | $14.21M derived: sum of 3 quarters · filed 2025-02-25 | $12.43M 10-K · filed 2025-02-25 |
| 2022-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $15.28M derived: sum of 2 quarters · filed 2023-11-08 | $13.50M 10-Q · filed 2023-11-08 | $14.32M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $14.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $12.35M 10-Q · filed 2023-08-08 | $13.16M derived: sum of 3 quarters · filed 2024-02-27 | $16.48M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$1.78M 10-Q · filed 2023-05-10 | -$960.00K derived: sum of 2 quarters · filed 2024-02-27 | $2.36M derived: sum of 3 quarters · filed 2024-02-27 | $8.14M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $820.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.14M derived: sum of 2 quarters · filed 2024-02-27 | $9.92M derived: sum of 3 quarters · filed 2024-02-27 | $16.03M 10-K · filed 2024-02-27 |
| 2021-09-30 | $3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $9.10M derived: sum of 2 quarters · filed 2022-11-07 | $15.21M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $5.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $11.89M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $6.11M 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $3.15M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | -$2.54M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |